| scholarly article | Q13442814 |
| P50 | author | James K. Min | Q16213661 |
| Michael J Pencina | Q37382178 | ||
| Sharmila Dorbala | Q89693043 | ||
| Daniel S Berman | Q89697826 | ||
| Leslee J Shaw | Q94570815 | ||
| Benjamin J W Chow | Q106879360 | ||
| Emir Veledar | Q114268000 | ||
| Marcelo F Di Carli | Q114294057 | ||
| Rob S B Beanlands | Q114406999 | ||
| Michael E Merhige | Q114407000 | ||
| P2093 | author name string | Brent A Williams | |
| P2860 | cites work | Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 |
| Coronary artery calcium score and risk classification for coronary heart disease prediction | Q34552221 | ||
| C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study | Q34552689 | ||
| Human Biodistribution and Radiation Dosimetry of 82Rb | Q35212024 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Improved cardiac risk assessment with noninvasive measures of coronary flow reserve | Q36390106 | ||
| New technology for noninvasive evaluation of coronary artery disease | Q36764400 | ||
| Radiation dose to patients from cardiac diagnostic imaging | Q36936679 | ||
| Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF | Q37637823 | ||
| Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study | Q37638667 | ||
| Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease | Q40030030 | ||
| Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography | Q40585925 | ||
| Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease | Q41650517 | ||
| Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography | Q43772936 | ||
| Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. | Q44489954 | ||
| Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. | Q46877957 | ||
| Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size. | Q47286597 | ||
| Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization | Q47386625 | ||
| What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? | Q50788281 | ||
| Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. | Q53248514 | ||
| Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. | Q53452706 | ||
| Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. | Q53474605 | ||
| ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab | Q77853784 | ||
| Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging | Q83883234 | ||
| Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia | Q84682517 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 176-184 | |
| P577 | publication date | 2012-12-05 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry | |
| P478 | volume | 61 |
| Q38905038 | Absolute quantification of myocardial blood flow |
| Q35761082 | Acceptance of Combined Coronary CT Angiography and Myocardial CT Perfusion versus Conventional Coronary Angiography in Patients with Coronary Stents--Intraindividual Comparison |
| Q27023690 | Advanced tracers in PET imaging of cardiovascular disease |
| Q38192519 | Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention? |
| Q26852383 | Cardiac PET perfusion: prognosis, risk stratification, and clinical management |
| Q28073135 | Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology |
| Q26859183 | Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease |
| Q26827495 | Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging |
| Q100694591 | Complete versus incomplete coronary revascularization: definitions, assessment and outcomes |
| Q37216087 | Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions |
| Q38432173 | Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence |
| Q38120658 | Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango |
| Q52991032 | Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease. |
| Q43577280 | Do we need PET? |
| Q90314103 | Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization |
| Q47876408 | Functional Information in Coronary Artery Disease: The Case of Computed Tomography Myocardial Perfusion |
| Q37464638 | Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets |
| Q49820811 | Interconnection of coronary macro- and microcirculation to each other: each component has relations that express all the others |
| Q50497994 | Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO. |
| Q38652030 | Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise |
| Q97520871 | Myocardial Perfusion Imaging Using Positron Emission Tomography |
| Q38741610 | Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations |
| Q59515630 | Myocardial perfusion imaging with PET |
| Q49908348 | Myocardial perfusion in patients with suspected coronary artery disease: comparison between 320-MDCT and rubidium-82 PET. |
| Q27011866 | New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease |
| Q38197125 | New insights from major prospective cohort studies with cardiac nuclear imaging |
| Q36610219 | Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries |
| Q39285234 | PET imaging in heart failure: the role of new tracers |
| Q92071803 | PET-Based Imaging of Ischemic Heart Disease |
| Q30456937 | PET/MRI: current state of the art and future potential for cardiovascular applications |
| Q37743798 | Pet Imaging and its Application in Cardiovascular Diseases |
| Q48314150 | Prediction of clinical outcome by myocardial CT perfusion in patients with low-risk unstable angina pectoris. |
| Q38439405 | Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD : 1: The value of PET: Integrating cardiovascular PET into the care continuum |
| Q35921040 | Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone |
| Q39360519 | Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging |
| Q87204060 | Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET |
| Q38901252 | Prognostic value of normal positron emission tomography myocardial perfusion imaging in patients with known or suspected coronary artery disease: a meta-analysis |
| Q40964410 | Prognostic value of positron emission tomography myocardial perfusion imaging beyond traditional cardiovascular risk factors: Systematic review and meta-analysis |
| Q47410400 | Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease |
| Q34660562 | Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study |
| Q38263600 | Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease |
| Q38122622 | Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography |
| Q44892949 | Registry |
| Q26825828 | Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging |
| Q38552516 | Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease. |
| Q57621157 | SPECT but not PET remains as the working horse of the state of the art nuclear cardiac imaging laboratory: Con |
| Q57680509 | Semi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference |
| Q38480969 | Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies |
| Q55601885 | The Status of Stress Myocardial Perfusion Imaging Using 99mTc Pharmaceuticals in Japan: Results from a Nationwide Survey. |
| Q86218597 | The benefits of advanced risk reclassification |
| Q39394208 | The impact of prompt gamma compensation on myocardial blood flow measurements with rubidium-82 dynamic PET. |
| Q46790828 | The prognosis for prognosis remains excellent |
| Q39548660 | The role of nuclear cardiac imaging in risk stratification of sudden cardiac death |
| Q38917554 | The role of positron emission tomography in the evaluation of myocardial ischemia in women |
| Q53054950 | The value and appropriateness of positron emission tomography: an evolving tale. |
| Q90674539 | Update of the Brazilian Guideline on Nuclear Cardiology - 2020 |
| Q40964313 | Use of observation followed by outpatient stress testing in chest pain patients with prior coronary artery disease history: An evaluation of prognostic utility |
| Q62711621 | Value Based Imaging for Coronary Artery Disease: Implications for Nuclear Cardiology and Cardiac CT |
| Q85849127 | Variability in normal myocardial blood flow measurements: physiologic, methodologic, or protocol related? |
Search more.